Your trusted destination for CME, CPD & Medical Education across the Middle East.
King Abdulaziz Medical City
Dr. Ayman Alhejazi is a distinguished consultant adult hematologist, bone marrow transplant physician, and clinical researcher whose work has significantly influenced the practice of hematologic oncology across the Kingdom of Saudi Arabia and the broader Gulf Cooperation Council (GCC) region. He earned his Bachelor of Medicine, Bachelor of Surgery (MBBS) degree before undertaking rigorous postgraduate residency and fellowship training in North America,attaining Fellowship status with the Royal College of Physicians and Surgeons of Canada (FRCPC) in both Internal Medicine and Adult Hematology, with specialized subspecialty training in Stem Cell Transplantation and Cellular Therapy.
Throughout a clinical career spanning over two decades at King Abdulaziz Medical City (KAMC-NGHA) in Riyadh, Dr.Alhejazi has established himself as a leading regional authority in the management of multiple myeloma,relapsed/refractory Hodgkin and non-Hodgkin lymphomas, chronic lymphocytic leukemia (CLL), and severe hemoglobinopathies such as sickle cell disease. His operative clinical work focuses on autologous and allogeneic hematopoietic stem cell transplantation, non-myeloablative conditioning protocols, and navigating novel immunotherapies including bispecific antibodies and CAR-T cell therapies.
Beyond his direct bedside clinical care, Dr. Alhejazi is a prolific scientific contributor and research leader. He has authored and co-authored over eighty peer-reviewed articles and consensus guidelines in major journals such as Frontiers in Medicine, Leukemia Research, Clinical Lymphoma, Myeloma & Leukemia, and JCO Global Oncology. His research contributions encompass real-world registry studies evaluating pharmacotherapy in multiple myeloma (such as the Greater Gulf REPAIR Study), consensus statements on bispecific antibody utilization, treatment-free remission (TFR) in chronic myeloid leukemia, and clinical management strategies for vulnerable immunocompromised cancer populations.
Dr. Alhejazi also holds key administrative and academic advisory roles, contributing directly to regional oncology guidelines, health system quality improvement projects (such as reducing futile acute care services for terminally ill patients), and training the next generation of hematologists and bone marrow transplant fellows at KSAU-HS.
At major regional scientific congresses, most notably the 7th Saudi Lymphoma/Myeloma and 10th Hematopathology Overview, Dr. Ayman Alhejazi is a featured keynote speaker and panel expert. Translating complex translational immunology and global trial data into daily clinical practice, he provides hematologists, oncologists, pathologists, and transplant specialists with practical, actionable strategies to optimize disease outcomes and elevate standards of care for patients across the region.

Saudi Society of Blood & Marrow Transplantation (SSBMT)
Saudi Society of Blood & Marrow Transplantation (SSBMT)

SSMC Training Academy
SSMC Training Academy